D mc af was a diluting piggy in
1st quarter 2018...
It should have it's own
trough, oops board, to
post on...
Dreams about revenue would
make great posting material...LJ
On March 29, 2018, the Company completed, in two tranches, a brokered and non-brokered private placement of
26,459,284 units at a price of $0.245 (CAD$0.31) per unit for aggregate gross proceeds of approximately $6.4
million, $5.8 million net of cash issuance costs (the “Offering”). Each unit consisted of one common share and
one half of one common share purchase warrant. Each whole warrant entitles the holder to purchase one common
DIAMEDICA THERAPEUTICS INC.
Notes to the Condensed Consolidated Interim Financial Statements
Three Months Ended March 31, 2018 and 2017
Amounts in United States Dollars
- 13 -
share at a price of $0.35 at any time prior to expiry on March 19, 2020 and March 29, 2020 for Tranche 1 and
Tranche 2, respectively. The warrant expiry date can be accelerated at the option of the Company, in the event
that the volume-weighted average trading price of the Company’s common shares exceeds $0.60 per common
share for any 21 consecutive trading days
News 
Market Data 
Discover 
